Banyan Biomarkers Inc., a Florida company developing in vitro diagnostic products to detect traumatic brain injury, has named Hague vice president of clinical and regulatory affairs. Hague comes to Banyan from Abbott Molecular, where she was director of clinical research. She will be responsible for taking the company’s proprietary immunoassays through clinical trials and the U.S. Food and Drug Administration’s premarket approval process.